Dual WEE1/YES1 Kinase Inhibitor MRANK-106 Secures FDA IND Clearance, Positioning MindRank in First-in-Class Oncology Pipeline
March 07, 2025 08:00 ET
|
MindRank
HANGZHOU, China and LONDON, March 07, 2025 (GLOBE NEWSWIRE) -- MindRank, a clinical stage artificial intelligence (AI)-empowered drug discovery company, announces today that the U.S. Food and Drug...
Innospec Expands Production of Drag Reducing Agents
March 03, 2025 09:00 ET
|
Innospec Inc.
ENGLEWOOD, Colo., March 03, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announces that it is expanding production capacity for its proprietary Drag Reducing Agent (DRA) technologies...
OKYO Pharma Receives $1.4 Million in Non-Dilutive Funding
January 22, 2025 07:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic...
DT Midstream Announces Closing of Midwest Pipeline Acquisition
December 31, 2024 09:00 ET
|
DT Midstream, Inc.
DETROIT, Dec. 31, 2024 (GLOBE NEWSWIRE) -- DT Midstream, Inc. (NYSE: DTM) today announced that it has successfully closed on the acquisition of a portfolio of three FERC-regulated natural gas...
Azuria Water Solutions Announces Acquisition of Pipe Pros LLC
December 20, 2024 10:40 ET
|
Azuria Water Solutions
Azuria Water Solutions announces the acquisition of Pipe Pros LLC
Azuria Water Solutions Announces the Acquisition of a portion of Miller Pipeline’s Municipal Services Division
November 06, 2024 09:00 ET
|
Azuria Water Solutions
Azuria Water Solutions™ today announced the acquisition of a portion of Miller Pipeline LLC’s municipal services division operations.
Tevogen Bio Plans to Share $1B+ Revenue Potential of its Pipeline Portfolio Beginning Week of October 14, 2024
October 11, 2024 15:59 ET
|
Tevogen Bio Inc
Tevogen Bio Plans to Share $1B+ Revenue Potential of its Pipeline Portfolio Beginning Week of October 14, 2024
Tevogen Bio Extends Pipeline Prioritizing Oncology and Long COVID
October 11, 2024 12:12 ET
|
Tevogen Bio Inc
Developing therapeutic products that not only treat cancer but also enable oncology patients to maintain uninterrupted therapy.Expanding its pipeline to include non-oncology products, an opportunistic...
Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress
September 26, 2024 07:00 ET
|
Mural Oncology, Inc.
Key data readouts for the company’s late-stage, potentially registrational trials of nemvaleukin are expected in late Q1/early Q2 2025 for platinum-resistant ovarian cancer and Q2 2025 for mucosal...
Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections
June 12, 2024 16:01 ET
|
Barinthus Biotherapeutics
Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections